Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
Ticker SymbolNNNN
CompanyAnbio Biotechnology
CEOLau (Michael)
Websitehttps://anbiobiotechnology.com/
FAQs
What is the current price of Anbio Biotechnology (NNNN)?
The current price of Anbio Biotechnology (NNNN) is 32.350.
What is the symbol of Anbio Biotechnology?
The ticker symbol of Anbio Biotechnology is NNNN.
What is the 52-week high of Anbio Biotechnology?
The 52-week high of Anbio Biotechnology is 55.650.
What is the 52-week low of Anbio Biotechnology?
The 52-week low of Anbio Biotechnology is 5.180.
What is the market capitalization of Anbio Biotechnology?
The market capitalization of Anbio Biotechnology is 4.65B.
What is the net income of Anbio Biotechnology?
The net income of Anbio Biotechnology is 2.37M.
Is Anbio Biotechnology (NNNN) currently rated as Buy, Hold, or Sell?
According to analysts, Anbio Biotechnology (NNNN) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Anbio Biotechnology (NNNN)?
The Earnings Per Share (EPS TTM) of Anbio Biotechnology (NNNN) is 0.017.